Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 203

Palo Alto applies for $150m Aporeto acquisition

Palo Alto Networks is set to pay $150m in cash to buy Aporeto, which had raised nearly $35m from investors including Comcast, Symantec, Telia and National Grid.

Nov 27, 2019

Sonos snaps up Snips

Sonos paid $37.5m to buy the voice app development platform, which had received more than $21m in funding from investors including Maif Avenir.

Nov 25, 2019

Google uploads CloudSimple

Cloud upload technology developer CloudSimple has become part of Google Cloud having raised funding from Microsoft subsidiary M12 last year.

Nov 25, 2019

Genetron gees itself up for $100m IPO

The Vcanbio-backed cancer diagnostics technology provider has filed to go public in the US having raised another $71m from investors including Alexandria Venture Investments.

Nov 22, 2019

Crystal Amber strikes at Allied Minds

Allied Minds' co-CEOs and chairman are under pressure from activist investor Crystal Amber despite having only taking their posts in June 2019.

Nov 22, 2019

Players’ Tribune gets a place at Minute Media

Sport media brand The Players Tribune has agreed to be acquired, after raising $58m from investors including GV, most recently at a $140m valuation.

Nov 22, 2019

Space Market races to IPO stage

Tokyo's Mothers Market has approved an initial public offering for the space provider that would enable Opt, CyberAgent, Tokyo Tatemono, JTB, Tokyo Metro, Mynavi and Recruit to exit.

Nov 22, 2019

Aon puts CoverWallet in its pocket

CV Starr and Zurich Insurance are set to exit business insurance provider CoverWallet in an acquisition by professional services firm Aon.

Nov 22, 2019

Biofourmis brings in Biovotion

Wearable health tracker developer Biovotion has been bought by digital therapeutics producer Biofourmis, enabling Swiss Re and STMicroelectronics to exit.

Nov 21, 2019

Alkermes readies $950m Rodin acquisition

The neurological disease therapy developer had raised about $57m from investors including Alphabet, Johnson & Johnson and Biogen.

Nov 20, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here